Author:
Xu Congmin,Mac Quoc D.,Jia Qiong,Qiu Peng
Publisher
Springer International Publishing
Reference37 articles.
1. Wlodarska, M., Ramnik, A.: An integrative view of microbiome-host interactions in inflammatory bowel diseases. Cell Host Microbe 17(5), 577–591 (2015)
2. Goyette, P., Boucher, G., et al.: High-density mapping of the mhc identifies a shared role for hla-drb1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat. Genet. 47(2), 172–179 (2015)
3. Bär, F., et al.: Inflammatory bowel diseases influence major histocompatibility complex class i (mhc i) and ii compartments in intestinal epithelial cells. J. Transl. Immunol. 172(2), 280–289 (2013)
4. Khan, I.: Alteration of gut microbiota in inflammatory bowel disease (ibd): cause or consequence? ibd treatment targeting the gut microbiome. Pathogens 8(3), 126 (2019)
5. Gevers, D., et al.: The treatment-naive microbiome in new-onset crohn’s disease. Cell Host Microbe 15(3), 382–392 (2014)